Skip to content

Multidisciplinary Team Approach: Working Together to Improve Glycemic Control in Hispanic Adults Diabetes

Multidisciplinary Team Approach: Working Together to Improve Glycemic Control in Hispanic Adults With Uncontrolled Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03463629
Enrollment
33
Registered
2018-03-13
Start date
2018-03-21
Completion date
2018-08-14
Last updated
2018-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Multidisciplinary Team, Hispanic adults

Brief summary

This study seeks to determine if a specialized multidisciplinary diabetes team (SMDT) approach that incorporates the use of the chronic care model can be an effective method for improving glycemic control in Hispanic adults with uncontrolled type 2 diabetes residing in the Rio Grande Valley. The study will expand the current model of care used and focus on the multidimensional aspects that consist of physical, nutritional, educational and psychological needs of this underserved Hispanic population residing in the Rio Grande Valley.

Interventions

OTHERSpecialized multidisciplinary diabetes team (SMDT) approach

The implementation of the pilot study will consist of a specialized multidisciplinary diabetes team care (SMDT) that includes endocrinologists, a nurse practitioner, dieticians, pharmacists and a licensed professional counselors (LPCs) to collaborate and coordinate care. Subjects in the pilot study will follow a multidisciplinary team approach process with the following team members: pharmacist, LPC, and dietician. There will be 3 individualized visits: 1 visit with the counselor (LPC), 1 visit with the Pharmacist, and 1 visit with the Dietician. In addition, a follow up phone call post visit, that can range from 5 to 30 minutes, will be scheduled from each of the team members during the study. Also, throughout the pilot study participant's blood glucose readings will be monitored weekly via a transmittable wireless patient transmission monitor.

OTHERTraditional model of care

Receive the traditional model of care, but will not receive diabetes education by pharmacists or counseling services

Sponsors

DHR Health Institute for Research and Development
CollaboratorOTHER
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Have physician-diagnosed type 2 diabetes * Be self-identified as Hispanic or Latino * An A1c value between 9-14% within the last three months * English or Spanish speaking

Exclusion criteria

* Type 1 diabetes or gestational diabetes * Cognitive impairment * Prisoners or individuals under detention * Unable to speak or understand English or Spanish * Medical history of the end-stage renal disease or undergoing dialysis.

Design outcomes

Primary

MeasureTime frameDescription
Change in glucose level as indicated by HbA1c levelsbaseline, 3 monthsIn this outcome, only the specialized multidisciplinary diabetes team (SMDT) arm (and not the traditional model of care arm) will be assessed.

Secondary

MeasureTime frame
Change in patient satisfaction with a multidisciplinary team approach management as indicated by a diabetes treatment satisfaction questionnaire (DTSQ)baseline, 3 months
Level of diabetes problem areas as assessed by the Problem Areas in Diabetes Questionnaire (PAID) questionnairebaseline, 3 months
Change in weightbaseline, 3 months
Change in blood pressurebaseline, 3 months
Change in body mass index (BMI)baseline, 3 months

Other

MeasureTime frameDescription
Glucose level as indicated by HbA1c levels3 monthsThe objective of this outcome is to compare and evaluate HbA1c results from participants that received care through a multidisciplinary diabetes team with patients that have received only the traditional model of care.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026